Tyrosine kinase inhibitor (second-generation)-related pancreatic toxicity in chronic myeloid leukemia patients analyzed using the FAERS database
Int. Journal of Clinical Pharmacology and Therapeutics · 13.10.2026
DOI: 10.5414/cp204979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 13.10.2026. Verfasst von Shiyu Wang und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, S., Luo, Q., He, N., Zou, Y., Lai, J., Yi, W., & Chen, J. (2026). Tyrosine kinase inhibitor (second-generation)-related pancreatic toxicity in chronic myeloid leukemia patients analyzed using the FAERS database. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204979
Vancouver
Wang S, Luo Q, He N, Zou Y, Lai J, Yi W, et al. Tyrosine kinase inhibitor (second-generation)-related pancreatic toxicity in chronic myeloid leukemia patients analyzed using the FAERS database. Int. Journal of Clinical Pharmacology and Therapeutics. 2026. doi:10.5414/cp204979
BibTeX
@article{Wang2026,
author = {Wang, Shiyu and Luo, Qingmao and He, Ning and Zou, Yu and Lai, Jinglun and Yi, Wenyan and Chen, Jiahao},
title = {Tyrosine kinase inhibitor (second-generation)-related pancreatic toxicity in chronic myeloid leukemia patients analyzed using the FAERS database},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
doi = {10.5414/cp204979}
}
EUVIMED